A discussion of the candidates for a COVID-19 vaccine, the usual timeline for vaccine development, and strategies for dramatically speeding that timeline up.
ChAdOx1 nCoV-19 Phase 1/2 Trial (The Lancet):
mRNA-1273 Phase 1 Trial (NEJM):
The New York Times Vaccine Tracker:
An overview of the most promising COVID vaccine candidates: